Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) is designed to be expressed as a single chain with three scFv units, two distal binding sites for CD19 and a central site for CD64. It contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD19 x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) (SCTB-H119). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS